Loading data
MGXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 25.21 m USD | 52.3 m USD | 44.76 m USD |
| Research and development expense | 94.43 m USD | 109.18 m USD | 94.4 m USD |
| Operating profit | -96.01 m USD | -88.9 m USD | -78.49 m USD |
| Profit before tax | -87.93 m USD | -83.57 m USD | -60.23 m USD |
| Income tax expense | -58 k USD | -5.51 m USD | 8.03 m USD |
| Net income (reported basis) | -87.87 m USD | -78.06 m USD | -68.26 m USD |
| Net income attributable to common shareholders | -87.87 m USD | -78.06 m USD | -68.26 m USD |
| Basic earnings per share | -2.36 USD/share | -2.36 USD/share | -20.05 USD/share |
| Diluted earnings per share | -2.36 USD/share | -2.36 USD/share | -20.05 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.